Health Care

The preeminent health care destination for capital markets advice and research coverage

Research capabilities for
Health Care sector

Cowen’s health care equity research is agenda-setting, and our footprint is among the largest. Our analysts’ work has been validated in third-party polls, such as Institutional Investor’s All-America Research Team, the Greenwich Associates poll, and Starmine. In addition to company-specific research, our team publishes over 17,000 pages of industry research annually. Publications such as Biotechnology Quarterly, Pharmaceutical Industry Pulse, Specialty Pharmaceutical Pulse, Therapeutic Categories Outlook, Life Science Tool Kit, and Diagnostics Kit have become legend among investors.


Similarly, our Ahead Of The Curve ™ reports are at the center of conversation.

Our annual Health Care Conference remains one of Wall Street’s most highly regarded, and is the epicenter of discussion for corporate executives, institutional investors, venture capitalists, and health care professionals.

Learn more about our research expertise


General Contact

Robert Fagin
Head of Research
D 646 562 1310

Stephen E. Reilly
Co-director of Research
D 617 946 3901

Lisa Thomas
Associate Director of Research
D 646 562 1388

Investment Banking capabilities for
Health Care sector

Cowen’s health care investment banking Group combines the global resources and full service product capabilities of a leading financial institution with the focus and commitment of a specialty investment banking firm.

Focused on financings and financial advisory for life sciences, medical technology and health care services companies our health care team have developed industry contacts which are leveraged to result in flawless execution and long-term client support.

Learn more about our investment banking expertise


Latest Transactions

  • Natera is a diagnostics company that has non-invasive tests to evaluate risk, and thereby enable early-detection of prenatal and oncology conditions.
  • Spero Therapeutics is focused on developing a novel and highly differentiated pipeline of antibacterials focused on the unmet needs of patients with drug resistant bacterial infections.
  • Zafgen is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for patients affected by a range of metabolic diseases


General Contact

George Milstein
Head of Health Care
D 415 646 7394